Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2019

Feb 28, 2019

29995_dirs_2019-02-28_2eb73bd9-1f4a-4e37-ad41-8e8008bbbb7c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2019-02-26

Reporting Person: Lippert Martin J (EVP Global Tech & Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-26 Common Stock A 35772 $44.65 Acquired 116087 Direct
2019-02-26 Common Stock F 16026 $44.65 Disposed 100061 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-26 Employee Stock Option (Right to Buy) $44.65 A 45363 Acquired 2029-02-25 Common Stock (45363) Direct
2019-02-26 Restricted Stock Units $ A 15118 Acquired Common Stock (15118) Direct

Footnotes

F1: Shares acquired from the payout of 2016-2018 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

F2: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout.

F3: The options become exercisable in three installments on February 26, 2020, 2021 and 2022.

F4: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022.